Loading stock data…
$1.21-0.01 (-0.82%)
Lite Strategy, Inc.
Lite Strategy, Inc. in the Healthcare sector is trading at $1.21 with a market capitalization of $28M. The stock is currently 46% below its 52-week high of $2.26, remaining 9.0% above its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$2.77M↑ | -$3.35M↓ | -$3.11M↓ | -$2.88M↓ | -$2.77M |
| Net Income | -$23.69M↑ | -$30.80M↓ | -$3.64M↓ | -$2.69M↓ | -$2.57M |
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. ...